Jane Street
LGND icon

Jane Street’s Ligand Pharmaceuticals LGND Stock Holding History

Jane Street’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$819K Sell
4,100
-4,100
-50% -$811K ﹤0.01% 6931
2025
Q4 		$1.55M Buy
8,200
+6,600
+413% +$1.27M ﹤0.01% 5282
2025
Q3 		$283K Buy
+1,600
New +$238K ﹤0.01% 9017
2022
Q4 		– Sell
-24,847
Closed -$1.33M – 9685
2022
Q3 		$1.33M Buy
+24,847
New +$1.46M ﹤0.01% 4905
2022
Q2 		– Sell
-17,633
Closed -$1.24M – 10358
2022
Q1 		$1.24M Sell
17,633
-41,518
-70% -$3.01M ﹤0.01% 5689
2021
Q4 		$5.7M Sell
59,151
-5,931
-9% -$548K ﹤0.01% 2658
2021
Q3 		$5.66M Sell
65,082
-19,076
-23% -$1.48M ﹤0.01% 2547
2021
Q2 		$6.89M Sell
84,158
-40,075
-32% -$3.33M ﹤0.01% 2190
2021
Q1 		$11.8M Buy
124,233
+106,440
+598% +$10.1M 0.01% 1397
2020
Q4 		$1.1M Buy
17,793
+2,564
+17% +$146K ﹤0.01% 4493
2020
Q3 		$906K Sell
15,229
-137,056
-90% -$9.35M ﹤0.01% 4249
2020
Q2 		$10.6M Sell
152,285
-19,717
-11% -$1.25M 0.01% 1143
2020
Q1 		$7.8M Buy
172,002
+155,651
+952% +$8.82M 0.01% 913
2019
Q4 		$1.06M Buy
+16,351
New +$1.09M ﹤0.01% 2693
2019
Q2 		– Sell
-10,580
Closed -$830K – 5475
2019
Q1 		$830K Buy
10,580
+6,252
+144% +$474K ﹤0.01% 3047
2018
Q4 		$366K Buy
+4,328
New +$461K ﹤0.01% 3835

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Jane Street's LGND Position: Q1 2026 in Review

Jane Street reduced its Ligand Pharmaceuticals (LGND) stake by 19% in Q1 2026, selling an estimated $605K and leaving 12,906 shares worth $2.58M. The position accounts for ﹤0.01% of the portfolio, ranked #4623.

Jane Street first reported a position in LGND in Q2 2013 and has held it in 35 quarters since. The position peaked at $9.19M in Q3 2025. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Jane Street held 12,906 shares of Ligand Pharmaceuticals worth $2.58M as of Q1 2026.
  • Jane Street sold 3,056 Ligand Pharmaceuticals shares in Q1 2026, an estimated $605K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4623 holding.
  • Jane Street first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 35 quarters since.
  • Jane Street's Ligand Pharmaceuticals position peaked at $9.19M in Q3 2025.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.